ALNY vs RSSS · P/E 76, rev $1.29B vs P/E 15, rev $49.1M
Alnylam Pharmaceuticals Inc (ALNY) versus Research Solutions Inc (RSSS) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Research Solutions Inc (RSSS) is a software - application company listed on NASDAQ.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported RSSS revenue for 2025-06-30 was $49.1M. Net income was $1.3M. RSSS currently screens at market cap $74.9M and trailing P/E 14.9.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. RSSS currently screens at market cap $74.9M and trailing P/E 14.9.
Not investment advice. Open the ALNY and RSSS stock pages for the full models.
Not investment advice.